Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study, a muscle contractile protein complex, actomyosin, has been successfully encapsulated into gellan-chitosan polyion complex (PIC) capsules. The recovery of the myosin-ATPase activity is approximately 50% and the
Mg2+-ATPase
activity is stimulated by the presence of F-actin, which implies the formation of the actomyosin complex inside the capsule. Furthermore, encapsulation could protect the myosin, F-actin, and actomyosin inside from hydrolysis by proteases. Two small proteins,
myoglobin
and cytochrome c, have been used in the release tests. The release of
myoglobin
is not affected by the ionic strength of the external solution, while the release of cytochrome c increases with increasing ionic strength. The maximal releases are found in the external pH solution close to the isoelectric points of each protein. The Mg2+-ATP complex itself reduces the release percentages of the small proteins from the PIC capsule. The release amounts further decrease when coexisting with Mg2+-ATP and the encapsulated actomyosin, which indicates the release regulation by actomyosin. The present study suggests that the ATPase-coupled sliding motion of the myosin-F-actin filaments modifies the pore size of the polymer networks in the PIC capsule membranes.
...
PMID:ATPase-coupled release control from polyion complex capsules encapsulating muscle proteins. 1742 32